CD74 Antikörper (FITC)
-
- Target Alle CD74 Antikörper anzeigen
- CD74 (HLA-DR-gamma (CD74))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CD74 Antikörper ist konjugiert mit FITC
-
Applikation
- Flow Cytometry (FACS)
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- CD74 (CD74 Antigen, DHLAG, Gamma Chain of Class II Antigens, HLA Class II Histocompatibility Antigen gamma Chain, HLA DR Antigens Associated Invariant Chain, HLA DR gamma, HLADG, I-a Antigen Associated Invariant Chain, I-a Associated Invariant Chain, I-a gamma, I-i, Invariant Polpypeptide of Major Histocompatibility Class II Antigen Associated, La Associated Invariant Chain, La gamma, Major Histocompatibility Complex Class II Invariant Chain, MHC HLA DR gamma Chain, p33, Protein 41) (FITC)
- Aufreinigung
- Purified by Protein G affinity chromatography.
- Immunogen
- B lymphoblastoid cell line HFB1.
- Klon
- 10B1960
- Isotyp
- IgG1
- Top Product
- Discover our top product CD74 Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.4, 1 % BSA, 0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- 4°C/-20°C (No Glycerol)
-
- Target
- CD74 (HLA-DR-gamma (CD74))
- Andere Bezeichnung
- CD74 (CD74 Produkte)
- Pathways
- Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Negative Regulation of intrinsic apoptotic Signaling, Cancer Immune Checkpoints
-